Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The adoption of drug-delivery capabilities to improve clinical and healthcare services and outcomes is increasing. As connected drug delivery devices can facilitate various services like adherence monitoring, training, and benefit tracking, the market is witnessing a healthy growth.
Clinicians are also preferring the deployment of connected drug delivery devices with embedded sensors and electronics to relay information regarding volume, time, and site of self-administration. Moreover, the growing demand for connected drug delivery devices to provide real-time insights to consumers by providing them access to their treatment data and the response of the body to their prescribed medication is likely to invigorate the market in the forecast period.
The increasing launches of innovative connected medical devices by the leading companies are augmenting the connected drug delivery devices market. In July 2020, the United States affiliate of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), Teva Respiratory, LLC., announced the launch of ProAir Digihaler Inhalation Powder, its digital rescue inhaler with built-in sensors. The inhaler is advised for patients aged four years and above for the prevention or treatment of exercise-induced bronchospasm and bronchospasm with reversible obstructive airway disease.
The device launched by Teva Respiratory connects to its mobile application through its built-in Bluetooth wireless technology sensors and provides information regarding the inhaler. It also records, detects, and stores inhaler event data such as peak respiratory flow and timestamps, enabling patients to view such records under its app. This would aid patients in improving the management and assessment of their conditions. The availability of the device would enhance the company’s portfolio in the United States.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The major players in the global connected drug delivery devices market are Adherium Limited, Propeller Health, Teva Pharmaceutical Industries Ltd., Phillips-Medisize (Molex, LLC), and Elcam Drug Delivery Devices, among others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.